Guardant Health, Inc. (GH) — Financial statements
Income statement, balance sheet, and cash flow for Guardant Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 982↑32.9% | 739↑31.0% | 564↑25.5% | 450↑20.3% | 374 | |
| Cost of Revenue | 349↑20.4% | 290↑27.6% | 227↑45.2% | 156↑27.2% | 123 | |
| Gross Profit | 633↑40.9% | 449↑33.3% | 337↑14.9% | 293↑16.9% | 251 | |
| Operating Expenses | ||||||
| R&D Expenses | 364↑4.7% | 348↓5.3% | 367↓1.8% | 374↑42.0% | 263 | |
| General & Administrative Expenses | 211↑17.4% | 180↑15.6% | 156↓5.0% | 164↓20.7% | 207 | |
| Selling & Marketing Expenses | 495↑35.5% | 365↑23.6% | 295↓1.5% | 300↑56.3% | 192 | |
| SG&A Expenses | 706↑29.5% | 545↑20.8% | 451↓2.8% | 464↑16.4% | 399 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 83 | 0.00 | 0.00 | |
| Operating Expenses | 1,070↑19.9% | 893↓1.0% | 902↑7.6% | 838↑26.6% | 662 | |
| Total Costs & Expenses | 1,419↑20.0% | 1,183↑4.8% | 1,129↑13.6% | 994↑26.7% | 785 | |
| Operating Results | ||||||
| Operating Income | -436↑1.6% | -444↑21.4% | -565↓3.7% | -544↓32.5% | -411 | |
| Depreciation & Amortization | 40↓6.3% | 42↓1.2% | 43↑19.2% | 36↑61.5% | 22 | |
| EBITDA | -374↑4.2% | -390↑10.0% | -433↑29.5% | -615↓71.0% | -360 | |
| EBIT | -414↑4.4% | -433↑9.2% | -476↑26.8% | -651↓70.4% | -382 | |
| Interest & Other Income | ||||||
| Net Interest Income | 30↓40.9% | 51↑55.9% | 33↑838.9% | 3↑158.1% | 1 | |
| Interest Income | 34↓36.5% | 54↑51.8% | 35↑482.7% | 6↑54.4% | 4 | |
| Interest Expense | 4↑51.0% | 3↑0.1% | 3↑0.0% | 3↑0.0% | 3 | |
| Non-Operating Income | -23↓104.4% | -11↑87.5% | -89↓183.1% | 106↑465.9% | -29 | |
| Other Income / Expenses | 19↑120.6% | 9↓90.1% | 86↑178.8% | -109↓511.1% | 27 | |
| Income Before Tax | -418↑4.0% | -435↑9.1% | -479↑26.7% | -653↓70.0% | -384 | |
| Income Tax Expense | -1↓198.4% | 1↑87.4% | 0.69↓39.9% | 1↑279.7% | 0.30 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -416↑4.6% | -436↑9.0% | -479↑26.8% | -655↓70.1% | -385 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -416↑4.6% | -436↑9.0% | -479↑26.8% | -655↓61.4% | -406 | |
| Bottom-Line Net Income | -416↑4.6% | -436↑9.0% | -479↑26.8% | -655↓61.4% | -406 | |
| EPS (Basic) | -3.32↑6.7% | -3.56↑16.8% | -4.28↑33.2% | -6.41↓68.7% | -3.80 | |
| EPS (Diluted) | -3.32↑6.7% | -3.56↑16.8% | -4.28↑33.2% | -6.41↓68.7% | -3.80 | |
| Weighted Average Shares | 125↑2.1% | 123↑9.6% | 112↑9.6% | 102↑0.9% | 101 | |
| Weighted Average Diluted Shares | 125↑2.1% | 123↑9.6% | 112↑9.6% | 102↑0.9% | 101 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.